K. Andersson, V. Odlind, and G. Rybo, Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: A randomized comparative trial, Contraception, vol.49, issue.1, pp.56-72, 1994.
DOI : 10.1016/0010-7824(94)90109-0

N. Bajos, M. Rouzaud-cornabas, H. Panjo, A. Bohet, and C. Moreau, La contraception en France : vers un nouveau modèle contraceptif ?, p.511, 2014.

B. Healthcare, Différenciation entre les deux systèmes de diffusion intra-utérins (SIU) existants Jaydess® et Mirena®, 2014.

A. Berenson, A. Tan, J. Hirth, and G. Wilkinson, Complications and Continuation of Intrauterine Device Use Among Commercially Insured Teenagers, Obstetrics & Gynecology, vol.121, issue.5, pp.951-958, 2013.
DOI : 10.1097/AOG.0b013e31828b63a0

A. Black, Dispositifs intra-utérins. Consensus canadien sur la contraception, J Obstet Gynaecol Can, vol.26, issue.3, pp.289-296, 2004.

M. Boudineau, O. Multon, and P. Lopes, Contraception par dispositif intra-ut??rin, EMC - Gyn??cologie, vol.1, issue.1, 2001.
DOI : 10.1016/S0246-1064(01)00051-2

C. Le-rôle-du-pharmacien and . Février-2015, http://www.cespharm.fr/fr/Preventionsante/L-education-pour-la-sante/Role-du-pharmacien

V. Y. Cheung, Sonographic Appearances of Chinese Intrauterine Devices, Journal of Ultrasound in Medicine, vol.29, issue.7, pp.1093-1101, 2010.
DOI : 10.7863/jum.2010.29.7.1093

M. Cox, J. Tripp, and S. Blacksell, Clinical performance of the levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report, Journal of Family Planning and Reproductive Health Care, vol.28, issue.2, pp.73-77, 2002.
DOI : 10.1783/147118902101196225

E. Derniaux, M. Lucereau-barbier, and O. Graesslin, Suivi et conseils apr??s infections g??nitales hautes, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.41, issue.8, pp.922-929, 2012.
DOI : 10.1016/j.jgyn.2012.09.023

R. S. French, Levonorgestrel-releasing (20 mug/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives, BJOG: An International Journal of Obstetrics and Gynaecology, vol.25, issue.10, pp.1218-1225, 2000.
DOI : 10.1016/0010-7824(89)90014-0

I. F. Gareen, S. Greenland, and H. Morgenstern, Intrauterine devices and pelvic inflammatory disease: meta-analyses of published studies, Epidemiology, vol.11, pp.1974-1990, 2000.

K. Gemzell-danielsson, I. Schellschmidt, and D. Apter, A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena, Fertility and Sterility, vol.97, issue.3, pp.616-622, 2012.
DOI : 10.1016/j.fertnstert.2011.12.003

D. A. Grimes, D. Hubacher, L. M. Lopez, and K. F. Schulz, Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use (intervention review), 2011.

H. Gronier, B. Letombe, F. Collier, D. Dewailly, and G. Robin, Mise au point sur la contraception intra-ut??rine en 15??questions-r??ponses, Gyn??cologie Obst??trique & Fertilit??, vol.40, issue.1, pp.37-42, 2012.
DOI : 10.1016/j.gyobfe.2011.07.022

J. Guillebaud and A. Macgregor, Contraception: your questions answered, 2013.

M. Harrison-woolrych, J. Ashton, and D. Coulter, Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported?, Contraception, vol.67, issue.1, pp.53-59, 2003.
DOI : 10.1016/S0010-7824(02)00417-1

H. Santé, Contraceptifs oraux estroprogestatifs : préférez les « pilules » de 1 e ou 2 e génération, 2012.

H. Santé, Efficacité des méthodes contraceptives, 2013.

H. Santé, Méthodes contraceptives : focus sur les méthodes les plus efficaces disponibles, 2013.

K. Heinemann, S. Reed, S. Moehner, D. Minh, and T. , Comparative Contraceptive Effectiveness of Levonorgestrel-Releasing and Copper Intrauterine Devices, Obstetrical & Gynecological Survey, vol.70, issue.5, 2015.
DOI : 10.1097/01.ogx.0000466339.43485.6e

L. Hu, Biological Evaluation of the Copper/Low-density Polyethylene Nanocomposite Intrauterine Device, PLoS ONE, vol.95, issue.9, p.74128, 2013.
DOI : 10.1371/journal.pone.0074128.t002

D. Hubacher, Pain from copper intrauterine device insertion: Randomized trial of prophylactic ibuprofen, American Journal of Obstetrics and Gynecology, vol.195, issue.5, pp.1272-1277, 2006.
DOI : 10.1016/j.ajog.2006.08.022

D. Hubacher and D. A. Grimes, Noncontraceptive Health Benefits of Intrauterine Devices: A Systematic Review, Obstetrical and Gynecological Survey, vol.57, issue.2, pp.120-128, 2002.
DOI : 10.1097/00006254-200202000-00024

D. Hubacher, R. Lara-ricalde, D. J. Taylor, F. Guerra-infante, and R. Guzmán-rodríguez, Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women, N, 2001.

I. Diu-?, Dispositif intra-utérin (stérilet) http

C. Jamin and P. Madelenat, DIU au cuivre : pourquoi choisir une contraception nonhormonale? Gynécologie Obstétrique & Fertilité, pp.2-5, 2010.

C. A. Janssen, P. C. Scholten, and A. P. Heintz, The effect of low-dose 3-keto-desogestrel added to a copper-releasing intrauterine contraceptive device on menstrual blood loss: A double-blind, dose-finding, placebo-controlled study, American Journal of Obstetrics and Gynecology, vol.182, issue.3, pp.575-581, 2000.
DOI : 10.1067/mob.2000.104805

I. Järvelä, T. Raudaskoski, A. Tekay, and P. Jouppila, Effect of the levonorgestrel-releasing intrauterine system on the uterine artery pulsatility index in postmenopausal hormone replacement therapy, Ultrasound in Obstetrics and Gynecology, vol.10, issue.5, pp.350-355, 1997.
DOI : 10.1046/j.1469-0705.1997.10050350.x

I. Järvelä, A. Tekay, and P. Jouppila, The effect of a levonorgestrel-releasing intrauterine system on uterine artery blood flow, hormone concentrations and ovarian cyst formation in fertile women, Human Reproduction, vol.13, issue.12, pp.3379-3383, 1998.
DOI : 10.1093/humrep/13.12.3379

V. Kalaichelvan, A. A. Maw, and K. Singh, Actinomyces in cervical smears of women using the intrauterine device in Singapore, Contraception, vol.73, issue.4, pp.352-355, 2006.
DOI : 10.1016/j.contraception.2005.09.005

J. Lansac, P. Lecomte, and H. Marret, Contraception locale, méthodes naturelles et contraceptions difficiles Gynécologie pour le praticien, pp.441-451, 2012.

O. Lidegaard, L. H. Nielsen, C. W. Skovlund, and E. Løkkegaard, Venous thrombosis in users of non-oral hormonal contraception: follow-up study, BMJ, vol.344, 2001.

J. Lippes, Pelvic actinomycosis: A review and preliminary look at prevalence, American Journal of Obstetrics and Gynecology, vol.180, issue.2, 1999.
DOI : 10.1016/S0002-9378(99)70198-5

L. M. Lopez, A. Edelman, M. Chen-mok, J. Trussell, and F. M. Helmerhorst, Progestin-only contraceptives: effects on weight, 2011.

H. Luo, Inhibition of DNA synthesis in isolated human endometrial cells by a levonorgestrel-releasing intrauterine device, Anal. Quant. Cytol. Histol, vol.21, pp.409-412, 1999.

E. Mandelin, H. Koistinen, R. Koistinen, B. Affandi, and M. Seppälä, Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?, Human Reproduction, vol.12, issue.12, pp.2671-2675, 1997.
DOI : 10.1093/humrep/12.12.2671

H. Marret, N. Wagner, L. Ouldamer, A. Jacquet, and G. Body, Actinomycose pelvienne??: est-ce pr??visible???, Gyn??cologie Obst??trique & Fertilit??, vol.38, issue.5, pp.307-312, 2010.
DOI : 10.1016/j.gyobfe.2010.03.006

M. Mazuy, L. Toulemon, and E. Baril, Un recours moindre à l'IVG, mais plus souvent répété. Populations & Sociétés, n°518, 2015.

C. Moreau, A. Bohet, J. Trussell, M. Leguen, and N. Bajos, Trends and determinants of use of long-acting reversible contraception use among young women in France: results from three national surveys conducted between 2000 and 2010, Fertility and Sterility, vol.100, issue.2, pp.451-459, 2000.
DOI : 10.1016/j.fertnstert.2013.04.002

C. Moreau, A. Bohet, V. Ringa, D. Hassoun, and C. Bajos, IUD use in France: women's and physician's perspectives, Contraception, vol.89, issue.1, pp.9-16, 2014.
DOI : 10.1016/j.contraception.2013.10.003

C. Moreau, J. Bouyer, N. Bajos, G. Rodríguez, and J. Trussell, Frequency of discontinuation of contraceptive use: results from a French population-based cohort, Human Reproduction, vol.24, issue.6, pp.1387-1392, 2009.
DOI : 10.1093/humrep/dep027

URL : https://hal.archives-ouvertes.fr/inserm-00464855

E. Nohuz, R. Battista, S. Tamburro, M. Leonenko, S. Bayeh et al., Un st??rilet qui fait de plus en plus mal??? o?? il ne suffit pas d???en voir les fils pour exclure une malposition??!, Gyn??cologie Obst??trique & Fertilit??, vol.42, issue.4, pp.261-264
DOI : 10.1016/j.gyobfe.2011.08.019

C. Panzer, S. Wise, G. Fantini, D. Kang, R. Munarriz et al., ORIGINAL RESEARCH???WOMEN's SEXUAL DYSFUNCTION: Impact of Oral Contraceptives on Sex Hormone???Binding Globulin and Androgen Levels: A Retrospective Study in Women with Sexual Dysfunction, The Journal of Sexual Medicine, vol.3, issue.1, pp.104-117, 2006.
DOI : 10.1111/j.1743-6109.2005.00198.x

G. Robin and B. Letombe, Contraceptions non hormonales, La revue du praticien, vol.58, pp.29-39, 2008.

I. Sivin and I. Batàr, State-of-the-art of non-hormonal methods of contraception, 2010.

I. Sivin, Prolonged intrauterine contraception: A seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS, Contraception, vol.44, issue.5, pp.473-480, 1991.
DOI : 10.1016/0010-7824(91)90149-A

I. Sivin, Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices, American Journal of Obstetrics and Gynecology, vol.166, issue.4, pp.1208-1213, 1992.
DOI : 10.1016/S0002-9378(11)90607-3

E. Stubbs and A. Schamp, The evidence is in. Why are IUDs still out? : family physicians' perceptions of risk and indications, Can Fam Physician, vol.54, pp.560-566, 2008.

S. Suhonen, M. Haukkamaa, T. Jakobsson, and I. Rauramo, Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study, Contraception, vol.69, issue.5, pp.407-412, 2004.
DOI : 10.1016/j.contraception.2003.11.008

P. Thonneau, T. Almont, E. De-la-rochebrochard, and B. Maria, Risk factors for IUD failure: results of a large multicentre case-control study, Human Reproduction, vol.21, issue.10, pp.2612-2616, 2006.
DOI : 10.1093/humrep/del208

N. Trignol-viguier, E. Blin, and H. Marret, Dispositif intra-ut??rin et nulliparit??, Gyn??cologie Obst??trique & Fertilit??, vol.42, issue.6, pp.432-437, 2014.
DOI : 10.1016/j.gyobfe.2014.04.003

X. B. Trinh, Use of the levonorgestrel-releasing intrauterine system in breast cancer patients, Fertility and Sterility, vol.90, issue.1, pp.17-22, 2008.
DOI : 10.1016/j.fertnstert.2007.05.033

M. P. Vessey, M. Lawless, K. Mcpherson, and D. Yeates, Fertility after stopping use of intrauterine contraceptive device., BMJ, vol.286, issue.6359, 1983.
DOI : 10.1136/bmj.286.6359.106

A. Vilain and M. C. Mouquet, Les interruptions volontaires de grossesse en 2013, Études et Résultats, 2015.

C. W. Wallwiener, L. Wallwiener, H. Seeger, A. O. Mück, J. Bitzer et al., Prevalence of Sexual Dysfunction and Impact of Contraception in Female German Medical Students, The Journal of Sexual Medicine, vol.7, issue.6, pp.2139-2148, 2010.
DOI : 10.1111/j.1743-6109.2010.01742.x

L. Wang, S. Li, S. Wu, Y. Zhao, and Y. Wang, A random control study of indomethacincontaining MYCu intrauterine contraceptive device for 60 months, Zhonghua Yi Xue Za Zhi, vol.93, pp.496-499, 2013.

J. C. Wilson, A prospective New Zealand study of fertility after removal of copper intrauterine contraceptive devices for conception and because of complications: A four-year study, American Journal of Obstetrics and Gynecology, vol.160, issue.2, pp.391-396, 1989.
DOI : 10.1016/0002-9378(89)90455-9

M. Winckler, La contraception du futur, 2003.

M. Winckler, Les dispositifs intra-utérins (DIU ou « stérilets »). Editions « J'ai Lu ». Contraceptions mode d'emploi, pp.269-333, 2007.